What is the initial treatment dosage of Atropine for organophosphate poisoning?

What is the initial treatment dosage of Atropine for organophosphate poisoning?

• A. 0.5-2 mg
• B. 1-2 grams
• C. 5-10 mg
• D. 0.1-0.5 mg

Answer: (A)

The initial treatment dosage of Atropine for organophosphate poisoning is in the range of 0.5 to 2 mg. This is based on Atropine's role as an anticholinergic agent, which counteracts the effects of excessive acetylcholine accumulation due to the inhibition of acetylcholinesterase by organophosphate compounds. When administered, Atropine works by blocking the muscarinic receptors in the body, thereby alleviating symptoms such as salivation, lacrimation, urinary incontinence, gastrointestinal distress, emesis (vomiting), and muscle twitching, which are all manifestations of cholinergic toxicity. This dosage range is appropriate as it allows for an immediate but controlled response to the poisoning, providing a basis for further titration based on the patient's clinical response. In cases of severe toxicity, higher doses may be required, but the initial dosage is crucial for quick intervention to stabilize the patient. It is important for responders to frequently reassess and adjust doses as necessary, ensuring a vital balance is maintained in managing the symptoms effectively.

The initial treatment dosage of Atropine for organophosphate poisoning is in the range of 0.5 to 2 mg. This is based on Atropine's role as an anticholinergic agent, which counteracts the effects of excessive acetylcholine accumulation due to the inhibition of acetylcholinesterase by organophosphate compounds. When administered, Atropine works by blocking the muscarinic receptors in the body, thereby alleviating symptoms such as salivation, lacrimation, urinary incontinence, gastrointestinal distress, emesis (vomiting), and muscle twitching, which are all manifestations of cholinergic toxicity.

This dosage range is appropriate as it allows for an immediate but controlled response to the poisoning, providing a basis for further titration based on the patient's clinical response. In cases of severe toxicity, higher doses may be required, but the initial dosage is crucial for quick intervention to stabilize the patient. It is important for responders to frequently reassess and adjust doses as necessary, ensuring a vital balance is maintained in managing the symptoms effectively.